Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ:HCAT)

3.890 -0.100 (-2.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 5 Next >
Costco's Price Target Cut By This Analyst? Plus Citigroup Sees $91 For Wynn Resorts
Raymond James cut the price target on Costco Wholesale Corporation (NASDAQ: COST) from $600 to $560. Raymond James analyst Bobby Griffin maintained an Outperform rating on the stock. Costco shares rose... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
This Analyst Slashes PT On Rent the Runway By Around 43%, Plus JP Morgan Predicts $84 For Oracle
Credit Suisse cut the price target for Rent the Runway, Inc. (NASDAQ: RENT) from $7 to $4. Rent the Runway shares fell 30.6% to trade at $3.42 on Tuesday. 
Via Benzinga
Short Volatility Alert: Health Catalyst, Inc.
On Friday, shares of Health Catalyst, Inc. (NASDAQ: HCAT) experienced volatile short activity. After the activity, the stock price went down -2.55% to $11.48. The overall sentiment for HCAT has been... 
Via Benzinga
7 Analysts Have This to Say About Health Catalyst
Within the last quarter, Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings: 
Via Benzinga
Short Volatility Alert: Health Catalyst, Inc.
On Tuesday, shares of Health Catalyst, Inc. (NASDAQ: HCAT) experienced volatile short activity. After the activity, the stock price went up +1.63% to $15.57. The overall sentiment for HCAT has been... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades See all analyst ratings upgrades. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Health Catalyst's Return On Capital Employed Overview
Benzinga Pro data, Health Catalyst (NASDAQ:HCAT) reported Q2 sales of $70.63 million. Earnings fell to a loss of $33.43 million, resulting in a 48.85% decrease from last quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... 
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers 
Via Benzinga
This Billion-Dollar Company Lost 40% Of Its Value, This Is What Wall Street Is Saying
Yesterday after the market close, Health Catalyst Inc (NASDAQ: HCAT) reported Q2 earnings. Shares have dropped over 30% after the news. SVB Leerink notes a mild Q2 beat on Tech outperformance and FY22... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday. 
Via Benzinga
Warner Bros. Discovery, Twilio, Monster Beverage And Some Other Big Stocks Moving Lower On Friday
  Health Catalyst, Inc. (NASDAQ: HCAT) fell 33.5% to $12.14 after the company issued weak sales forecast and announced a $40 million share repurchase program. JP Morgan and Stifel also downgraded the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
Upgrades 
Via Benzinga
Markets Open Lower; U.S. Economy Adds Higher-Than-Expected Jobs In July
U.S. stocks traded lower this morning, following the release of jobs data 
Via Benzinga
Synaptics To $205? Plus Stifel Cuts Twilio's PT From $200 To This Level
Stifel cut the price target for Twilio Inc. (NYSE: TWLO) from $200 to $90. Twilio shares fell 9.6% to $88.75 in pre-market trading. 
Via Benzinga
Recap: Health Catalyst Q2 Earnings
Health Catalyst (NASDAQ:HCAT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Health Catalyst beat... 
Via Benzinga
Health Catalyst Earnings Preview
Health Catalyst (NASDAQ:HCAT) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Health... 
Via Benzinga
7 Small-Cap Growth Stocks Trading at a Huge Discount Right Now
If you’re comfortable with the risks involved with small-cap stocks, here are seven small-cap growth stocks trading at a discount right now. 
Via InvestorPlace
7 Small-Cap Growth Stocks With 1,000% Upside Potential
Here're 7 small-cap growth stocks with 1,000% upside potential. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments. 
Via InvestorPlace
Health Catalyst's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Health Catalyst's (NASDAQ:HCAT) reported sales totaled $68.09 million. Despite a 54.16% increase in earnings, the company posted a loss of $22.46... 
Via Benzinga
Recap: Health Catalyst Q1 Earnings
Health Catalyst (NASDAQ:HCAT) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Health Catalyst beat estimated... 
Via Benzinga
Where Health Catalyst Stands With Analysts
Over the past 3 months, 8 analysts have published their opinion on Health Catalyst (NASDAQ:HCAT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
What 7 Analyst Ratings Have To Say About Health Catalyst
Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
Upgrades 
Via Benzinga
Health Catalyst's Return On Capital Employed Overview
Health Catalyst (NASDAQ:HCAT) brought in sales totaling $64.72 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 22.44%, resulting in a... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.